Fluidigm Stock News

Fluidigm press release (NASDAQ:FLDM): Q4 Non-GAAP EPS of -$0.01 beats by $0.17.Revenue of $38.27M (-14.2% Y/Y) beats by $5.57M.

SOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive hea

SOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced financial results for the fourth quarter and full year ended December 31, 2021.

SOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive healt

SOUTH SAN FRANCISCO, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM) today filed with the U.S. Securities and Exchange Commission (the “SEC”) a preliminary proxy sta

SOUTH SAN FRANCISCO, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM) today filed with the U.S. Securities and Exchange Commission (the “SEC”) a preliminary proxy state

Fluidigm Corporation (NASDAQ:FLDM) with the stream of 4.85% also noticed, India Mustang Bio, Inc. (NASDAQ:MBIO) encountered a rapid change of 0.00% in the last hour of Mondays trading session. Fluidigm The post Remarkable Stock Buzz: Fluidigm Corporation (NASDAQ:FLDM), Mustang Bio, Inc. (NASDAQ:MBIO) appeared first on Stocks Equity .

The "Global Spatial OMICS Market, By Sample Type, By End Use, By Technology, By Product, By Workflow, Estimation & Forecast, 2018 - 2028" report has been added to ResearchAndMarkets.com''s offering. The global spatial OMICS market held a market value of USD 230.2 million in 2020 and is estimated to reach USD 506.6 million by the year 2028. The market is anticipated to register a CAGR of 10.3% during the forecast period. Companies Mentioned 10x Genomics S2 Genomics, Inc. NanoString Technologies Seven Bridges Genomics PerkinElmer, Inc. Bio-Techne Danaher Corporation IonPath, Inc. Millennium Science Pty Ltd Akoya Biosciences, Inc. Fluidigm Corporation Diagenode Diagnostics Biognosys AG Rebus Biosystems Ultivue, Inc. BioSpyder Technologies Bruker Spatial omics combines the molecular scrutiny with spatial data on the cell''s localization in the interior of the tissue. Omics is a term brief for numerous diverse studies, such as epigenomics, genomics, transcriptomics, lipidomics proteomics, and metabolomics, among others.

Fluidigm Corporation: Investment Opportunity

Fluidigm Corporation (NASDAQ: FLDM ) has approved a $250 million investment by Casdin Capital LLC and Viking Global Investors LP with zero-coupon convertible preferred shares with a conversion price of $3.40/share. The investment will significantly advance the Company''s mission through new organic and inorganic growth initiatives while optimizing its cost structure. Upon closing of Full story available on Benzinga.com

Fluidigm (FLDM) announces a $250M investment by Casdin Capital and Viking Global Investors. Casdin and Viking will buy $250M of zero-coupon convertible preferred shares with…

Mission to Reinvigorate Growth through Optimization of Mass Cytometry and Microfluidics Platforms and Portfolio Expansion via Strategic Acquisitions

Fluidigm Corporation (NASDAQ: FLDM) has approved a $250 million investment by Casdin Capital LLC and Viking Global Investors LP with zero-coupon convertible preferred shares with a conversion p

Mission to Reinvigorate Growth through Optimization of Mass Cytometry and Microfluidics Platforms and Portfolio Expansion via Strategic Acquisitions